Abstract Posttranslational modification is a common cellular process that is used by cells to ensure a particular protein function. This can happen in a variety of ways, e.g., from the addition of phosphates or sugar residues to a particular amino acid, ensuring proper protein life cycle and function. In this review, we assess the evidence for ubiquitination, glycosylation, phosphorylation, S-nitrosylation as well as other modifications in connexins and pannexin proteins. Based on the literature, we find that posttranslational modifications are an important component of connexin and pannexin regulation.
Introduction
Posttranslational modification is a common method by which proteins can be modulated by intrinsic or extrinsic factors to potentiate or initiate a specific function. It is now well accepted that these modifications are a key way in which a protein can become useful in the context of cellular physiology. This is not different when it comes to the connexin and pannexin family of proteins, where a fairly broad range of modifications has now been described that can alter the function of these proteins, from the dramatic (e.g., opening or closing of the channel/gap junction/ hemichannel) to the subtle (e.g., insertion into specialized lipid rafts).
Connexin and pannexin proteins are transmembrane proteins that allow for the passive diffusion of signaling molecules through their pores. Connexins are the key components to gap junctions, linking the cytoplasms of two opposing cells and allowing for rapid electrical or chemical integration among cells in a tissue. These proteins, when composed as a gap junction, allow for several functions, including electrical coordination of cardiac myocytes or ciliary beat frequency between tracheal epithelium, with several mutations in connexins associated with disease states (Boitano and Evans 2000; Johnson and Koval 2009; Kelsell et al. 2001; Lai et al. 2006; Palatinus and Gourdie 2007) . Undocked connexin hemichannels have also been hypothesized to play a more paracrine role in cellular communication in more pathological states (De Vuyst et al. 2007; Pearson et al. 2005) . While membrane topology is similar to that of connexins, pannexins share no sequence homologies with connexins and are a more recently identified class of transmembrane proteins (Panchin et al. 2000) . Pannexins can be found in three different isoforms (Panx1, Panx2 and Panx3) encoded by three different genes, with Panx1 and Panx3 sharing more similarities to each other than to Panx2 (Penuela et al. 2007 ). In the past decade, a growing body of literature has revealed that pannexins play multiple roles as they have been shown to release ATP and participate in calcium wave propagation and are likely a component of the inflammasome (Dando and Roper 2009; Locovei et al. 2006; Silverman et al. 2009; Sridharan et al. 2010 ). Thus, both connexins and pannexins are critical for cells to coordinate direct and paracrine communication (Fig. 1) . In this review, we aim to bring together data focusing on the roles for glycosylation, phosphorylation, S-nitrosylation, ubiquitination and other posttranslational modifications in regulating the functions of both connexin and pannexin proteins.
Glycosylation
Glycosylation is a form of posttranslational modification which consists of the enzymatic addition of glycans to form glycosylated proteins. The enzyme glycosyltransferase catalyzes the attachment of glycans to a nitrogen of asparagine (N-linked glycosylation) or to a hydroxyl oxygen of threonine or serine (O-linked glycosylation) residues (Freeze and Sharma 2010; Reis et al. 2010) . Glycosylation mostly occurs in the endoplasmic reticulum (ER) or Golgi apparatus and can affect protein folding and stability, influence protein trafficking and interfere with protein function (Pinho et al. 2011; Reis et al. 2010; Roth et al. 2010) .
Connexin proteins are not glycosylated despite identification of the N-glycosylation consensus sequence in Cx32 (Martin and Evans 2004; Rahman et al. 1993; Saez et al. 2003 ). However, it should be noted that a few reports have shown that inhibition of protein glycosylation in cells transfected with Cx43 can increase trafficking of Cx43 to the plasma membrane, its phosphorylation and its opening indirectly via a cAMP pathway .
Currently, the primary identified posttranslational modification in pannexins is glycosylation. Glycosylation of the Panx1 isoforms leads to a migration shift on SDS gel with bands representing three different glycosylation states, whereas the multiple band pattern of Cx43 has been demonstrated to represent different phosphorylated states (Boassa et al. 2007 (Boassa et al. , 2008 Penuela et al. 2007 Penuela et al. , 2009 Solan and Lampe 2009) . The different glycosylation states of Panx1 result in a multiple banding pattern on a Western blot, with the Gly2 species migrating slower than Gly1 as an intermediate band and the Gly0 species being the fastest-migrating form (Boassa et al. 2007 (Boassa et al. , 2008 Penuela et al. 2007 Penuela et al. , 2009 . Of the three pannexin isoforms, Panx1 and Panx3 have been shown to be glycosylated and their glycosylation sites have been defined, whereas the glycosylation site of Panx2 has only been predicted (Boassa et al. 2007 (Boassa et al. , 2008 Penuela et al. 2007 Penuela et al. , 2009 Penuela et al. , 2012 .
Panx1 and Panx3 are N-glycosylated on the amino acids asparagine (N) 254 and N71, respectively, and can be found in three different states: a core unglycosylated protein (Gly0), a high mannose-glycosylated protein (Gly1) and an extensively glycosylated species (Gly2) (Boassa et al. 2007; Penuela et al. 2007 Penuela et al. , 2009 ). The role of N-glycosylation of Panx1 was explored using site-directed mutagenesis of N254 targeted by N-glycosylation (Panx1 N254Q ) (Boassa et al. 2007 (Boassa et al. , 2008 Penuela et al. 2007 Penuela et al. , 2008 . Similarly, the role of Panx3 N-glycosylation was investigated using the mutant Panx3 N71Q (Penuela et al. 2007 (Penuela et al. , 2008 . These glycosylation mutants exhibit reduced trafficking to the plasma membrane when transfected in different cell lines, suggesting an important role for N-glycosylation in Panx1 and Panx3 trafficking (Boassa et al. 2007 (Boassa et al. , 2008 Penuela et al. 2007 Penuela et al. , 2008 . However, despite the low amount of Panx1 N254Q and Panx3 N71Q at the plasma membrane, the mutated proteins still form channels, as evidenced by dye uptake measurements (Penuela et al. 2007 (Penuela et al. , 2009 ). Additionally, when wild-type Panx1 and Panx1 N254Q are cotransfected, the trafficking of the glycosylation mutant to the plasma membrane is rescued, showing that they cooligomerize and suggesting that N-glycosylation does not play a role in oligomerization of Panx1 (Boassa et al. 2008) .
Altogether, these studies demonstrate that the Gly0 species appears primarily after protein synthesis, whereas Gly1 is associated within the ER and Gly2 is modified in the Golgi apparatus prior to plasma membrane insertion. However, it should be noted that all Panx1 glycosylated species are capable of trafficking to the plasma membrane but the Gly2 form is preferentially trafficked (Gehi et al. 2011) .
Phosphorylation
Posttranslational modification through phosphorylation acts as a major regulatory pathway in normal protein life Fig. 1 Schematic list of posttranslational modifications throughout the life span of connexins and pannexins. Numbers are the amino acids in the proteins as indicated in the references. Note that only when amino acids or specific regions on the protein could be identified were they included in the figure; e.g., although palmitoylation has been indicated for Panx2 (Swayne et al. 2010) , the exact region on the protein remains unknown. *Shown indirectly through PKA; #this cysteine is assumed to be S-nitrosylated in a hemichannel (based on Retamal et al. 2006 ) but has not been directly shown; ?data are now in dispute according to Dunn et al. (2012) . 1 cycles and can be further affected in pathological states by upregulation of kinase pathways. These pathways regulate protein functions through addition of a phosphate group by kinases to serine (S), threonine (T) and tyrosine (Y) sites, which may lead to alterations in the hydrophobicity, charge and potentially structural reorganization of proteins, either promoting or inhibiting normal functions (Davis 2011; Huttlin et al. 2010; Nishi et al. 2011 ).
Phosphorylation of connexins has been extensively demonstrated and reviewed (particularly for Cx43) and is integral in their life cycle-altering protein oligomerization, trafficking, membrane insertion and aggregation, gap junction communication and internalization from the membrane (Laird 2005; Laird et al. 1995; Marquez-Rosado et al. 2011; Saez et al. 1990 Saez et al. , 1998 Lampe 2005, 2009 ). Phosphorylation has been demonstrated for multiple S/T/Y sites through c-and v-SRC; mitogen-activated protein kinase (MAPK), protein kinase C (PKC), protein kinase A (PKA), P34 cdc (CDC2), casein kinase 1 (CK1) and calmodulin-dependant protein kinase pathways (Lampe and Lau 2004; Saez et al. 1998; Lampe 2005, 2009) .
Posttranslational modification through phosphorylation of cytoplasmic residues primarily occurs within the connexin carboxyl terminus. Additionally, phosphorylation sites in the Cx43 amino terminus (S5) and the Cx56 intracellular loop have been identified as phosphorylated (Berthoud et al. 1997; Chen et al. 2012; Wisniewski et al. 2010 ). Cx43 does not contain serines within its intracellular loop and is therefore not modified directly by phosphorylation within this region . As a result of a short 19-amino acid carboxyl terminus containing only two serines, Cx26 is the only isoform that is currently considered not to be posttranslationally modified through phosphorylation (Traub et al. 1989) . Conversely, Cx43 contains a total of 66 S/T/Y sites (32 in the carboxyl terminus) and has been demonstrated to be highly regulated through phosphorylation primarily at serine residues (Chen et al. 2012; Crow et al. 1990; Marquez-Rosado et al. 2011) .
Phosphoproteomic analyses used to determine the incidence of protein phosphorylation in vitro and across multiple tissues, ranging from brain, kidney, lung, spleen and more, derived from mice, rats and humans have demonstrated that Cx43 as well as Cx47, Cx32 and Cx29 are phosphorylated at multiple sites at their carboxyl terminus as well as the amino terminus (Brill et al. 2009; Cooper et al. 2000; Huttlin et al. 2010; Rikova et al. 2007; Wisniewski et al. 2010) . These studies and others further suggest that connexins are regulated by complex multisite phosphorylation, which plays an important role in the rapid generation and turnover of connexin proteins in a multitude of tissues and organ systems (Chen et al. 2012; Johnson and Vaillancourt 1994) . This area of study will become increasingly important in terms of understanding how multiple phosphorylation events can ''tip the balance'' one way or another toward a particular protein function.
Connexins are posttranslationally oligomerized to hexameric hemichannels prior to membrane insertion either within the ER (e.g., Cx26, Cx32) (Falk et al. 1997; Falk and Gilula 1998) or in the trans-Golgi network (e.g., Cx43, Cx46) (Das Sarma et al. 2001; del Castillo et al. 2009; Koval 2006; Koval et al. 1997; Musil and Goodenough 1993; Puranam et al. 1993) . A role for connexin phosphorylation in channel oligomerization has not currently been demonstrated . Pulse-chase studies have shown that newly synthesized Cx43 can be rapidly phosphorylated and dephosphorylated (within 15-30 min) (Crow et al. 1990 ) in the ER and Golgi compartments (Laird et al. 1995) . In addition, monomeric Cx43 phosphoisoforms have been identified, which suggests that Cx43 is phosphorylated prior to insertion into the plasma membrane (Musil and Goodenough 1993) . Further, increases in PKA activity can promote Cx43 integration to the membrane and are associated with Cx43-S364 phosphorylation, but Cx43 is a poor substrate for PKA and does not appear to directly increase Cx43 phosphorylation, suggesting that other intermediary pathways mediate the response (Paulson et al. 2000; TenBroek et al. 2001) . Data demonstrating nonphosphorylated isoforms of connexins at the membrane suggest that they can be inserted to the membrane without phosphorylation (although transient phosphorylations could occur prior to entry to the membrane (Musil et al. 1990; Musil and Goodenough 1991; Solan and Lampe 2005) . This is also evident with truncated mutations of Cx43 (D252) oligomerizing and trafficking to the plasma membrane. These truncated channels still form functional channels, suggesting that phosphorylation on the carboxyl tail is not a critical requirement (Johnstone et al. 2009; Martinez et al. 2003) . Regardless, deletion mutagenesis studies have demonstrated that a portion of the Cx43 carboxyl terminus is required for trafficking. By creating a carboxyl terminus deletion at amino acid 236, Cx43 cannot traffic to the membrane, while deletions after amino acid 239 (D243/D239) traffic to the membrane and form gap junctions (De Vuyst et al. 2007; Wayakanon et al. 2012) . As with Cx43, Cx45 requires its carboxyl terminus to target the membrane. Phosphorylation does not significantly alter Cx45 trafficking to the membrane but may affect protein half-life (Hertlein et al. 1998) . Current data therefore suggest that phosphorylation of connexins is not a critical determinant of oligomerization and membrane insertion but could be involved in efficient gap junction assembly and trafficking.
The open and closed states of connexin hemichannels exist as a balance between inhibition and stimulation of carboxyl terminal residues. Mutagenesis studies of Cx43 have shown that mutations after amino acid 239 in Cx43 can still form functional gap junctions but inhibit hemichannel opening, suggesting that regulatory sites within the carboxyl terminus are required for hemichannel opening (De Vuyst et al. 2007 ). In general, connexin phosphorylation through PKC (e.g., S368) and MAPK activity maintains a closed hemichannel state (Bao et al. 2004a (Bao et al. , 2007 Chandrasekhar and Bera 2012; Contreras et al. 2002; Ek-Vitorin et al. 2006; Kwak and Jongsma 1996; Schulz and Heusch 2004; Srisakuldee et al. 2009 ). Indeed, it has been shown that direct phosphorylation of Cx43-S368 by PKC reduces hemichannel opening (Bao et al. 2004b) . Similarly, treatments with lipopolysaccharide and basic fibroblast growth factor decrease hemichannel activity in Cx32-, Cx43-and Cx26-expressing HeLa cells (De Vuyst et al. 2007 ). However, the same treatments enhance hemichannel opening in C6-Cx43 cells (De Vuyst et al. 2007 ). This diversity in hemichannel signaling has been attributed to a balance between channel inhibition (phosphorylation) and stimulation (dephosphorylation) modifications on the connexin carboxyl terminus (Contreras et al. 2002; De Vuyst et al. 2007 ).
As described above, the carboxyl terminus of connexins (particularly Cx43) may act to promote efficient gap junction assembly from hemichannels. Once inserted to the membrane, hemichannels aggregate in ''formation plaques'' prior to incorporation into the gap junctional plaque (Johnson et al. 2012; Segretain and Falk 2004) . Truncation mutants of Cx43 result in reduced hemichannel aggregation and gap junction plaque formation, suggesting that phosphorylation of carboxyl-terminal residues may be involved in efficient delivery of hemichannels to the gap junction plaque (Johnson et al. 2012; Palatinus et al. 2011a) . Increased formation and stability of gap junctions have been associated with PKA and CK1 activity. Increases in intracellular cAMP levels promote PKA activity, which promotes (indirectly) Cx43-S364 phosphorylation and increases in gap junction assembly and coupling (TenBroek et al. 2001) . CK1 phosphorylation of Cx43-S325/S328/S330 also appears to promote gap junction assembly and stability (Cooper and Lampe 2002) . Gap junction aggregation occurs through directed trafficking by chaperone proteins, e.g., zonula occludens-1/2 (ZO-1/ZO-2) (Rhett et al. 2011; Singh et al. 2005) . Associations between the Cx43 carboxyl terminus and ZO-1 promote targeting to gap junction plaques (Hunter et al. 2005; Jin et al. 2004; Toyofuku et al. 1998 ). This can be disrupted through c-SRC phosphorylation of Cx43-Y265, which appears to be a critical site in the binding of ZO-1 (Toyofuku et al. 2001) . Therefore, phosphorylation may allow for efficient and directed movement of connexins within the membrane to sites of gap junction plaques.
In general, for Cx43, CK1 (and PKA) pathways increase and PKC, MAPK, v-SRC, and CDC2 reduce gap junctional communication (Pahujaa et al. 2007; Solan and Lampe 2005 ). Phosphorylation-induced increases in gap junctional communication occur through CK1 phosphorylation of Cx43-S325/S328/S330 (Cooper and Lampe 2002) and by PKA (Cx43-S364, indirectly) (TenBroek et al. 2001) . However, as mentioned, these sites are also associated with increased gap junction assembly; and it has been suggested that they may enhance plaque stability, leading to a prolonged life cycle (Remo et al. 2011 ). In addition, phosphorylation of Cx40 by PKA pathways leads to altered (higher) conductance states .
PKC activity reduces Cx43 gap junctional communication. Reduced unitary conductance occurs following Cx43-S368 phosphorylation (Ek-Vitorin et al. 2006; , and site-directed mutagenesis demonstrates that Cx43-S262 phosphorylation can reduce gap junctional communication, which in turn may act to promote DNA synthesis and cell cycle progression (Doble et al. 2004 ). The impact of reduced communication through PKC phosphorylation of Cx43-S368 ranges from promoting wound closure (potentially by isolating cells from surrounding signals and promoting differentiation) (Richards et al. 2004 ), causing decreased cell-to-cell communication in the vascular wall (Straub et al. 2009 ) and reducing ischemia-reperfusion injury in hearts (Palatinus et al. 2011b) . MAPK phosphorylation of Cx43-S255/S279/S282 leads to reductions in gap junctional communication by inhibiting the ability of the channels to open (Cottrell et al. 2003; Warn-Cramer et al. 1998) . It should also be noted that several sites in the Cx43 tail may be phosphorylated through multiple pathways as is demonstrated for PKC induction by phorbol 12-myristate 13-acetate, which promotes Cx43 S279/S282 phosphorylation Lampe 2007, 2009 ). In addition to the classically accepted MAPK sites, Norris et al. (2008) demonstrated that Cx43-S262 sites were phosphorylated (but not S368) through MAPK pathways, leading to reduced gap junctional communication and meiotic resumption in mouse oocytes. Increases in CDC2 promote phosphorylation of Cx43-S255 and reductions in gap junctional communication, which are associated with progression through the cell cycle (Kanemitsu et al. 1998; Lampe et al. 1998 ). Activation of v-SRC pathways leads to phosphorylation of Cx43-Y247 and Cx43-Y265, which appears to occur in formed gap junctions, leading to a reduction in gap junctional communication (Solan and Lampe 2008) . In addition to these sites, active v-SRC can cause phosphorylation at sites associated with PKC and MAPK in Cx43 (Solan and Lampe 2008) .
Less is known for the other connexins. Sequence predictions and homology suggest that Cx37 may be similarly phosphorylated through MAPK pathways, potentially at Cx37-S275 and Cx37-S282, which may affect gap junctional assembly and communication; but this has not been directly demonstrated (Burt et al. 2008) . Phosphorylation of Cx45 through PKC pathways alters the occupancy time and conductive state of the channel (Kwak et al. 1995; . Although Cx45 is primarily phosphorylated at serines, substitution of all carboxyl-terminus serines does not alter gap junctional communication in HeLa cells (Hertlein et al. 1998) .
Phosphorylation also plays a role in the internalization of connexins from the gap junctional plaque and has been shown to alter the protein turnover rates for several connexins (Laird 2005) . During the cell cycle Cx43 appears to be dynamically regulated at the S, G 1 , G 2 and M phases, all represented by alterations in Cx43 phosphorylation and internalization. As the cell cycle progresses, Cx43 appears at more intracellular locations and is highly phosphorylated at CDC2, PKC and MAPK sites, suggesting that phosphorylation may be involved in the removal of the connexins from the membrane gap junction plaques. However, it has not been conclusively demonstrated whether this results from removal of connexins from gap junction plaques or from reduced assembly to plaques (Solan and Lampe 2009) . In mitosis, phosphorylation of Cx43 by CDC2 at the S255 and S262 regions is associated with an internalization of the protein (Kanemitsu et al. 1998; Lampe et al. 1998; Xie et al. 1997) . During the cell cycle Cx43-S368 phosphorylation is also associated with a reduction in gap junction plaque size and protein internalization Solan et al. 2003) . Conversely, it has been noted that dephosphorylation of Cx43 (S365) promotes an intracellular redistribution of Cx43 (Beardslee et al. 2000; or removal of Cx43 plaques (Laird et al. 1995) . Substitution of Cx45-S381/S382/S384/S385 residues, but not the remaining serines from the carboxyl terminus of Cx45, significantly reduces the protein half-life by approximately 50 %, suggesting that these sites are involved in protein degradation (Hertlein et al. 1998 ). More recently, the MAPK phosphorylation of Cx43 at S255/262/279/282 was identified as critical to binding with cyclin E and promotion through the cell cycle (Johnstone et al. 2012) .
While phosphorylation of connexins is integral to their functionality, much less has been demonstrated for modulation of pannexin channels. Despite this, all mammalian forms of pannexins contain multiple S/T/Y sites (Penuela et al. 2007 ). Currently, there are limited structural data for the pannexins and their carboxyl-terminus regions (Ambrosi et al. 2010 ). The membrane topology of pannexins appears to resemble that of the connexins with a cytoplasmic amino terminus, intracellular loop and carboxyl terminus, which shows the greatest sequence variability in the Panx2 isoform . As with the connexins, the carboxyl-terminus regions are rich in S/T/Y sites. Consensus sequences for S/Y/T phosphorylation have been predicted based on sequence and membrane topology for pannexins 1-3 to occur primarily in the carboxyl terminus with fewer intracellular loop motifs (Barbe et al. 2006; Penuela et al. 2007) . It has been shown that Panx1 ATP release can be induced by P2X 7 R activation through tyrosine kinase pathways, but it is not clear whether Panx1 is directly phosphorylated or regulated through intermediary pathways (Iglesias et al. 2009 ). While data on phosphorylation of pannexins are currently in their infancy, there is clearly the potential for this posttranslational modification in the regulation of the protein life cycle or function.
Nitrosylation
Posttranslational modification can also occur through Snitrosylation, in which nitric oxide (NO) can bind to a reactive cysteine (C) thiol, producing an S-nitrosothiol (SNO) (Stamler et al. 1992) . While proteins often contain multiple cysteine residues, the majority of the observed biological effects imparted by NO occur on single or only a few cysteine residues within a protein. In addition to direct modification of proteins by S-nitrosylation, this posttranslational modification can indirectly regulate other protein modifications including acetylation, phosphorylation and ubiquitination (Hess and Stamler 2012; Park et al. 2004; Whalen et al. 2007; Yasukawa et al. 2005) .
The effects of NO on hemichannels and gap junctions have primarily been investigated in vascular cell types including vascular endothelial and smooth muscle cells. Of particular note, it was initially shown that exogenous application of the NO donor S-nitroso-N-acetylpenicillamine to cultured human umbilical vein endothelial cells significantly decreased dye transfer between coupled cells in a Cx37-dependent manner (Kameritsch et al. 2005 ). The observed decrease in gap junction permeability was independent of the effects of NO on guanylate cyclase and cGMP levels, indicating a separate effect of NO on the channels. In a separate study, NO application significantly reduced electrical coupling between cultured human microvascular endothelial cells mediated by effects on gap junctions composed of Cx37, which was similarly independent of cGMP (McKinnon et al. 2009 ). Conducted vasoconstriction in cremasteric arterioles has been shown to be dependent on Cx37 gap junctions and, importantly, is impaired during sepsis, a pathology resulting in upregulation of nNOS and increased NO production (McKinnon et al. 2006) .
While S-nitrosylation of gap junctions composed of Cx37 has not been directly observed, evidence has indicated the ability of Cx43 to be S-nitrosylated; and this modification has been suggested to regulate gap junction permeability at the myoendothelial junction (MEJ) in the blood vessel wall (Straub et al. 2011) . In this study, Cx43 was found to be locally enriched along with eNOS at the MEJ. Importantly, Cx43 was constitutively S-nitrosylated at C271. The S-nitrosylation of C271 on Cx43 was directly correlated with an open channel probability as denitrosylation significantly reduced heterocellular communication at the MEJ, namely, the movement of inositol triphosphate from smooth muscle cells to endothelial cells through Cx43 gap junctions. In agreement, pharmacological inhibition or genetic depletion of the denitrosylase GSNOR, which indirectly affects the extent of S-nitrosylation in these cells by reducing denitrosylation of the NO donor S-nitrosogluathione (GSNO), significantly increased gap junctional communication at the MEJ. Altogether this study suggests the potential for connexin proteins to become S-nitrosylated at specific cysteine residues, with the modification affecting channel permeability.
S-nitrosylation has also been proposed to regulate the permeability of undocked Cx43 hemichannels at the plasma membrane. During prolonged periods of ischemia or hypoxia, oxygen deprivation induces the opening of Cx43 hemichannels in cortical astrocytes and cardiomyocytes, leading to cell death (Contreras et al. 2002; John et al. 1999; Kondo et al. 2000) . The mechanisms regulating Cx43 hemichannel permeability under these conditions have been suggested to involve dephosphorylation of Cx43 hemichannels (a known stimulus for hemichannel activation (Bao et al. 2004b; Kim et al. 1999) or oxidative modification due to increased production of reactive oxygen species, including NO. A novel study by Retamal et al. (2006) found that metabolic inhibition of cortical astrocytes resulted in both dephosphorylation of Cx43 hemichannels as well as an increase in S-nitrosylation, ultimately leading to an increase in cellular permeability as determined by dye uptake. Interestingly, application of reducing agents to these cells did not affect Cx43 phosphorylation but significantly reduced both cell permeability and Cx43 S-nitrosylation. In agreement with this, application of exogenous NO donors results in increased cell permeability. Together, these observations indicate a functional role for Cx43 S-nitrosylation in regulating hemichannel permeability at the plasma membrane of astrocytes.
The potential regulation of hemichannels composed of Cx46 by NO has also been suggested. When expressed in Xenopus oocytes, Cx46 hemichannels exhibited increased voltage sensitivity and current amplitude upon application of GSNO, as assessed by patch-clamp electrophysiology (Retamal et al. 2009 ). Treatment of these cells with the reducing agent dithiothreitol (DTT) reversed the effects of GSNO on hemichannel currents, and mutation of the two endogenous carboxyl-terminus cysteine residues inhibited the effect of GSNO application. These observations suggest that critical cysteine residues in the carboxyl terminus of Cx46, like C271 in Cx43, may be modified by S-nitrosylation to regulate channel permeability.
Of the three pannexin isoforms characterized to date, Panx1 is the most widely expressed and is highly expressed in vascular smooth muscle and endothelial cells in the arterial vasculature (Billaud et al. 2011; Godecke et al. 2012; Lohman et al. 2012 ) and in multiple cell types in the central and peripheral nervous systems (Ray et al. 2005; Vogt et al. 2005; Xia et al. 2012) . Importantly, all these tissues have enriched NOS expression and actively utilize NO for signaling. As Panx1 contains multiple cysteine residues and has been shown to be expressed in tissues with enhanced NO production, it is possible that Panx1 channels in these cells may be regulated posttranslationally by Snitrosylation. Further, it has been shown that mutation of C346 in the carboxyl terminus of Panx1 results in a constitutively leaky channel (Bunse et al. 2010) . Also, mutation of C40 in the pore-lining region of the first transmembrane domain of Panx1 produces a constitutively open channel (Bunse et al. 2011) . These results indicate the importance of Panx1 cysteine residues in regulating channel gating and permeability. While there are currently no published reports indicating direct modulation of Panx1 channels by S-nitrosylation, studies have indicated a role for Panx1 (as well as Panx2) channels in ischemia-induced neuronal cell death, a condition in which NO production is markedly enhanced (Bargiotas et al. 2011) . Similarly, oxygen glucose deprivation and metabolic inhibition, conditions similar to ischemia, both induced excessive NO production and neuronal cell death mediated by opening of Panx channels, which was attenuated by pharmacological blockade of nNOS or reduction of oxidized cysteine thiols with the reducing agent DTT (Zhang et al. 2008 ). Importantly, inhibition of guanylate cyclase in these experiments had little effect on Panx channel permeability, suggesting potential effects of NO by S-nitrosylation of Panx channels in these cells. Future studies will be essential to directly evaluate the potential for pannexin proteins to be posttranslationally modified by S-nitrosylation and how modification of Panx channels in this manner affects channel gating and permeability.
Ubiquitination
The ubiquitin proteasome system regulates the degradation of many proteins. This can occur at the absolute N-terminal primary amine of proteins to induce autophagy (e.g., Lichtenstein et al. 2011) . Although this is a relatively new area of connexin research, it could be quite important in multiple disease states. More traditional ubiquitination is comprised of several components, including E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes and E3 ubiquitin ligases, that together mediate the transfer of the 76-amino acid protein ubiquitin to specific lysine (K) residues on target proteins (Leithe and Rivedal 2007; Willis et al. 2010) . Multiple ubiquitins can be covalently linked via K48 to form polyubiquitin chains, which target the ubiquitinated protein for degradation by the multisubunit 26S proteasome (Leithe and Rivedal 2007; Voges et al. 1999; Willis et al. 2010) . Both connexins and pannexins have multiple lysine residues to which ubiquitin may be conjugated. Connexins can be ubiquitinated on K9 and K303 (Wagner et al. 2011) , while pannexins can have ubiquitin conjugated to K409 (Kim et al. 2011) . Thus, the possible ubiquitination of connexins and pannexins implies that these proteins may be regulated by proteasomal degradation.
Several studies have suggested that connexins and pannexins are ubiquitinated and degraded by the proteasome. The proteasomal inhibitor N-acetyl-L-leucyl-L-leucinyl-norleucinal increased levels of Cx43 (Laing and Beyer 1995) and Cx31 (He et al. 2005 ) and prolonged Cx43 half-life. Furthermore, immunoprecipitation with antibodies against Cx43 and ubiquitin suggested that Cx43 might be polyubiquitinated (Laing and Beyer 1995), indicating that disrupting the ubiquitin proteasome system could alter connexin turnover. The tumorigenic compound phorbol ester 12-O-tetradecanoylphorbol 13-acetate initiated hyperphosphorylation and ubiquitin-mediated degradation of Cx43, which was prevented by proteasomal inhibitors (Leithe and Rivedal 2004) , demonstrating the importance of phosphorylation in ubiquitin-mediated connexin degradation. Phosphorylation of connexins facilitates interaction with proteins of the ubiquitin proteasome system, such as the ubiquitin ligase Nedd4 (Leykauf et al. 2006) . Disrupting the interaction between connexins and ubiquitin proteasome proteins via proteasomal inhibitors alters the interaction between Cx43 and ZO-1, leading to Cx43 accumulation into enlarged gap junctions at plasma membranes (Girao and Pereira 2007). Therefore, it has been suggested that the ubiquitin proteasome system most likely contributes to the internalization and degradation of connexins.
Despite these findings, there is mounting evidence against ubiquitination and proteasomal degradation of connexins. Degradation of ER-localized Cx43 by the proteasome is partly controlled by Cx43 interactions with the ubiquitin-like protein CIP75, which binds to ubiquitinated substrates. However, immunoprecipitation studies demonstrated that the CIP75-bound Cx43 was not directly ubiquitinated (Su et al. 2010) . In addition, a mutant Cx43 construct in which all lysine residues were converted to arginines mimicked the response of wild-type Cx43 to proteasomal inhibitors (Dunn et al. 2012) . Taken together, these results indicate that direct ubiquitination may not be required for proteasomal degradation of Cx43. Instead, ubiquitination of connexins may contribute to other pathways regulating turnover. Indeed, recent studies have linked Cx43 monoubiquitination to lysosomal degradation. Following internalization from the plasma membrane, Cx43 can associate with the ubiquitin-binding proteins Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate) and Tsg101 (tumor susceptibility gene 101) and the ubiquitin-binding endocytic adaptor protein Eps15, which shuttle Cx43 along the endocytic pathway for subsequent degradation in lysosomal compartments (Girao et al. 2009; Leithe et al. 2009 ). Thus, although ubiquitination mediates connexin trafficking and other degradative pathways, it is not clear whether direct ubiquitination is an important step during proteasomal degradation. Connexin turnover by this pathway most likely involves interaction between ubiquitinated substrates, even if connexins themselves are not tagged with ubiquitin.
Perturbation of connexin degradation by the ubiquitin proteasome has physiological and pathological consequences. Connexins are dynamically regulated with a short half-life of 1-6 h (He et al. 2005; Leithe and Rivedal 2004; Musil et al. 2000; Su et al. 2010) . Proper connexin turnover rate is vital to maintain normal physiological functions (Li and Wang 2010) . Dysregulation of dynamic gap junction protein turnover via inhibition of the ubiquitin proteasome degradation pathway (e.g., from oxidative stress) increases gap junction plaque size and enhances gap junction communication (Girao and Pereira 2007) . Inhibition of proteasome-mediated degradation of gap junction proteins and enhanced gap junction communication is associated with several cardiovascular pathologies, such as ischemia-reperfusion injury, cardiac proteinopathy (i.e., irregular protein aggregation), post-myocardial infarct arrhythmias and heart failure (Beardslee et al. 1998; Li and Wang 2010) . Thus, the ubiquitin proteasome pathway may provide novel therapeutic targets to treat cardiovascular diseases by restoring proper turnover of cardiac proteins, including connexins.
Much less is known about the involvement of the ubiquitin proteasome system in pannexin degradation. Mass spectrometric screens have identified K409 as a probable site of ubiquitination (Kim et al. 2011 ). However, biochemical evidence for pannexin ubiquitination and proteasomal degradation is lacking. A recent study has shown that Panx1 internalization and lysosomal degradation are controlled by its carboxyl-terminus region, but Panx1 does not appear to be degraded by traditional endocytic pathways (Gehi et al. 2011) . Thus, further studies are needed to investigate the role ubiquitination plays in pannexin turnover (Schalper et al. 2012 ).
Other Modifications

SUMOylation
It has now been demonstrated that connexins (i.e., Cx43) can be targeted for posttranslation modification by less characterized pathways, e.g., SUMOylation. The small ubiquitin-like modifier (SUMO) family of proteins acts in most cellular compartments to adapt proteins in multiple processes including transcription, translation, cellular transport, protein interactions, cell growth and programmed cell death (Geiss-Friedlander and Melchior 2007) . In Cx43, L144 (intracellular loop) and L237 (carboxyl terminus) can be SUMOylated, leading to a reduction in protein expression and gap junction formation (Kjenseth et al. 2012) . Consensus motifs for SUMOylation have been identified in the Panx2 sequence; however, studies of immunoprecipitated Panx2 from mouse neuronal stem cells differentiated to neurospheres showed a lack of detection of SUMO1/2/3, suggesting that Panx2 is not SUMOylated (Swayne et al. 2010) . Given the diversity of activity of SUMO proteins, this posttranslational modification could potentially play a significant role in connexins and pannexin protein regulation and channel formation.
Lipid Modification, e.g., Palmitoylation
The correct insertion of transmembrane proteins into the plasma membrane is a delicate process that involves the coordination of protein modifications for the binding of specific phospholipids (termed ''palmitoylation''). It has been well described that connexins are associated with lipid rafts, especially those enriched with caveoli (e.g., Langlois et al. 2008; Locke et al. 2005) . However, only the carboxyl terminus of Cx32 (amino acids 277-283) has been identified to have a palmitoylation site (Locke et al. 2006) . Regardless, this concept was further elucidated by a series of experiments designed to identify all the phospholipids that could be associated with either Cx26 or Cx32 gap junctions. The authors found that the lipids associated with the two homotypic gap junctions were dramatically different, indicating these connexins may reside in very distinct parts of the plasma membrane (Locke and Harris 2009), possibly placed there by palmitoylation modifications.
Thus far, there is no indication that pannexin isoforms associate with caveolin (Gehi et al. 2011 ). However, it has been demonstrated that Panx2 has distinct depalmitoylated and palmitoylated species that migrate at different molecular weights (*60 and *85 kDa, respectively) as determined by treatment of Western blots with hydroxylamine or metabolically labeling cells with BODIPY FL hexadecanoic acid. Swayne et al. (2010) further suggested that the palmitoylated form of Panx2 resides in the Golgi and/or ER, whereas the depalmitoylated form resides primarily at the plasma membrane and indicates these changes are associated with differentiation of neuronal cells. Elucidation of the exact site where Panx2 may be palmitoylated could prove quite interesting.
Caspase Cleavage
The posttranslational modification of proteins is generally considered to be a reversible process. However, a new type of terminal posttranslational modification was recently described where the Panx1 protein was cleaved by caspase 3 during apoptosis, inducing a constitutive open state of the channel for the release of ATP (Chekeni et al. 2010; Dunn et al. 2012 ). The caspase 3 cleavage site was identified in human Panx1 at amino acids 376-379 (DVVD) (Chekeni et al. 2010) . The implications from the work were that the carboxyl terminus of Panx1 could regulate the pore open or closed state. This concept was recently demonstrated in a novel experimental model (Sandilos et al. 2012) . In this work the authors inserted a TEV sequence into the Panx1 caspase cleavage site, allowing for controlled enzymatic cleavage of the carboxyl terminus. Next, a disulfide bond between the carboxyl terminus (C426) and an engineered cysteine within the pore of the Panx1 channel prevented removal of the carboxyl terminus from the pore (Sandilos et al. 2012) . Finally, cleavage of the carboxyl terminus by TEV protease failed to produce current, and only after disulfide bond removal was current through the Panx1 channel restored (Sandilos et al. 2012) . When summed with the caspase cleavage, the data indicate a role for the carboxyl terminus in regulating an open or closed pore and that cleavage of the carboxyl terminus as the specific caspase cleavage site induces a constitutive open channel during apoptosis. Although multiple connexins have been implicated throughout the apoptotic pathway (e.g., Andrade-Rozental et al. 2000; Minogue et al. 2009; Seul et al. 2004) , there are no direct links or functional results like that described for the action of caspase 3 on Panx1.
Conclusion
Although much has been learned about how posttranslational modifications can have dramatic or subtle effects on connexin and pannexin function, most of these discoveries have happened only in the last decade. The creation of more specific antibodies toward modified amino acids (e.g., Solan and Lampe 2008) and accessibility of proteomic arrays to more researchers will enable an even greater study of posttranslational modifications associated with connexins and pannexins and their functional effect.
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